Skip to content

COX: what changed

BE 0426.728.635NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€85,004
2024 · €109,680-€24,677
Equity
€742,431
2024 · €710,904+€31,528
Cash
€234,890
2024 · €174,761+€60,129
Balance sheet total
€917,941
2024 · €854,045+€63,897

Largest movements

2024 to 2025
Assets
  • Cash +€60,129

    up €60,129 (+34.4%), from €174,761 to €234,890

    mainly Net result for the year (+€85,004) and Depreciation (+€46,781)

  • Stocks and contracts +€23,397

    up €23,397 (+15.0%), from €156,318 to €179,715

  • Tangible fixed assets -€9,430

    down €9,430 (-3.2%), from €291,417 to €281,987

    of which Plant, machinery and equipment: -€33,261

Equity and liabilities
  • Reserves +€31,528

    up €31,528 (+4.6%), from €692,312 to €723,839

    of which Distributable reserves: +€31,528

  • Tax, wage and social debts +€21,427

    up €21,427 (+51.3%), from €41,759 to €63,186

    of which Taxes: +€16,942

  • Trade debts +€9,924

    up €9,924 (+10.9%), from €91,238 to €101,162

Income statement
  • Staff costs +€20,484

    up €20,484 (+13.0%), from €157,854 to €178,338

  • Gross operating margin +€12,965

    up €12,965 (+3.6%), from €361,150 to €374,115

  • Financial charges +€12,029

    up €12,029 (+322%), from €3,736 to €15,764

  • Depreciation +€9,756

    up €9,756 (+26.3%), from €37,025 to €46,781

  • Taxes -€6,664

    down €6,664 (-12.6%), from €52,877 to €46,213

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €109,680
Gross operating margin +€12,965
Staff costs -€20,484
Depreciation -€9,756
Other operating charges -€1,278
Financial income -€759
Financial charges -€12,029
Taxes +€6,664
Result 2025 €85,004
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€150,956
Investment -€37,351
Financing -€53,476
Cash 2024 €174,761
Net result for the year +€85,004
Depreciation +€46,781
Stocks and contracts -€23,397
Receivables within one year +€5,834
Deferred charges and accrued income +€4,365
Trade debts +€9,924
Tax, wage and social debts +€21,427
Other debts -€5,503
Accrued charges and deferred income +€6,521
Investment in fixed assets (net) -€37,351
Contributions, distributions and other -€53,476
Cash 2025 €234,890
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €854,045 €917,941 +€63,897 +7.5%
Fixed assets 21/28 €291,417 €281,987 -€9,430 -3.2%
Tangible fixed assets 22/27 €291,417 €281,987 -€9,430 -3.2%
Land and buildings 22 €42,205 €40,478 -€1,728 -4.1%
Plant, machinery and equipment 23 €246,749 €213,489 -€33,261 -13.5%
Furniture and vehicles 24 €2,462 €28,021 +€25,559 +1,038%
Current assets 29/58 €562,628 €635,954 +€73,327 +13.0%
Stocks and contracts in progress 3 €156,318 €179,715 +€23,397 +15.0%
Stocks 30/36 €156,318 €179,715 +€23,397 +15.0%
Amounts receivable within one year 40/41 €150,705 €144,870 -€5,834 -3.9%
Trade receivables 40 €129,394 €144,870 +€15,477 +12.0%
Other amounts receivable 41 €21,311 €0 -€21,311 -100%
Current investments 50/53 €64,369 €64,369 = 0.0%
Cash at bank and in hand 54/58 €174,761 €234,890 +€60,129 +34.4%
Deferred charges and accrued income 490/1 €16,474 €12,109 -€4,365 -26.5%
Total equity and liabilities 10/49 €854,045 €917,941 +€63,897 +7.5%
Equity 10/15 €710,904 €742,431 +€31,528 +4.4%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €692,312 €723,839 +€31,528 +4.6%
Tax-exempt reserves 132 €35,558 €35,558 = 0.0%
Distributable reserves 133 €656,754 €688,282 +€31,528 +4.8%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €143,141 €175,510 +€32,369 +22.6%
Amounts payable within one year 42/48 €139,372 €165,220 +€25,848 +18.5%
Trade debts 44 €91,238 €101,162 +€9,924 +10.9%
Suppliers 440/4 €91,238 €101,162 +€9,924 +10.9%
Taxes, remuneration and social security 45 €41,759 €63,186 +€21,427 +51.3%
Taxes 450/3 €15,071 €32,013 +€16,942 +112%
Remuneration and social security 454/9 €26,688 €31,173 +€4,485 +16.8%
Other amounts payable 47/48 €6,375 €872 -€5,503 -86.3%
Accrued charges and deferred income 492/3 €3,769 €10,290 +€6,521 +173%
Non-recurring operating income 76A - €8,300 +€8,300
Remuneration, social security and pensions 62 €157,854 €178,338 +€20,484 +13.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €37,025 €46,781 +€9,756 +26.3%
Other operating charges 640/8 €3,810 €5,088 +€1,278 +33.6%
Gross operating margin 9900 €361,150 €374,115 +€12,965 +3.6%
Operating profit (loss) 9901 €162,461 €143,908 -€18,553 -11.4%
Financial income 75/76B €3,832 €3,073 -€759 -19.8%
Recurring financial income 75 €3,832 €3,073 -€759 -19.8%
Financial charges 65/66B €3,736 €15,764 +€12,029 +322%
Recurring financial charges 65 €3,736 €15,764 +€12,029 +322%
Profit (loss) for the period before taxes 9903 €162,558 €131,217 -€31,341 -19.3%
Income taxes 67/77 €52,877 €46,213 -€6,664 -12.6%
Profit (loss) for the period 9904 €109,680 €85,004 -€24,677 -22.5%
Profit (loss) for the period to be appropriated 9905 €109,680 €85,004 -€24,677 -22.5%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€664,119 to €781,281

Midpoint €712,937 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €742,431
Capitalised earnings €585,807 to €820,130
Indication €664,119 to €781,281

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€742,431
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€742,431

Capitalised earnings

net result for the year (9904)
2025
€85,004
excluding non-recurring income and charges
€76,704
2024
€109,680
2023
€59,655
2022
€116,219
2021
€124,606
Average result, excluding non-recurring income and charges
€82,013
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€585,807 / €683,442 / €820,130

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.